Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice

• Hauptverfasser: Lieqiang Xu (VerfasserIn), Juanjuan Cheng (VerfasserIn), Jieyi Lu (VerfasserIn), Guoshu Lin (VerfasserIn), Qiuxia Yu (VerfasserIn), Yucui Li (VerfasserIn), Jiannan Chen (VerfasserIn), Jianhui Xie (VerfasserIn), Ziren Su (VerfasserIn), Qi Zhou (VerfasserIn)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Hyperuricemia (HUA), a common metabolic disease, is treated as the second-largest metabolic disease after diabetes in China. Cortex Phellodendri (CP) is one of the most frequently used herbal medicines for treating gout or HUA. However, the mechanism underlying the anti-HUA effect of CP is still unr...